Epigenetics Drugs and Diagnostic Technologies Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Epigenetics Drugs and Diagnostic Technologies in Global, including the following market information:
Global Epigenetics Drugs and Diagnostic Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Epigenetics Drugs and Diagnostic Technologies market was valued at 9268.1 million in 2021 and is projected to reach US$ 26730 million by 2028, at a CAGR of 16.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HDAC inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epigenetics Drugs and Diagnostic Technologies include Varlix Plc, Topotarget, Syndax Pharmaceuticals, Spectrum Pharmaceuticals, Promega, Novartis, Oncolys BioPharma, MDxHealth and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetics Drugs and Diagnostic Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epigenetics Drugs and Diagnostic Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, by Type, 2021 (%)
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, by Application, 2021 (%)
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Epigenetics Drugs and Diagnostic Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Epigenetics Drugs and Diagnostic Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Epigenetics Drugs and Diagnostic Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Epigenetics Drugs and Diagnostic Technologies market was valued at 9268.1 million in 2021 and is projected to reach US$ 26730 million by 2028, at a CAGR of 16.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HDAC inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epigenetics Drugs and Diagnostic Technologies include Varlix Plc, Topotarget, Syndax Pharmaceuticals, Spectrum Pharmaceuticals, Promega, Novartis, Oncolys BioPharma, MDxHealth and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetics Drugs and Diagnostic Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epigenetics Drugs and Diagnostic Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, by Type, 2021 (%)
- HDAC inhibitors
- DNMT inhibitors
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, by Application, 2021 (%)
- Non coding RNA’s
- Micro RNA’s
- Histone modifications
- DNA methylation
Global Epigenetics Drugs and Diagnostic Technologies Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Epigenetics Drugs and Diagnostic Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Epigenetics Drugs and Diagnostic Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Varlix Plc
- Topotarget
- Syndax Pharmaceuticals
- Spectrum Pharmaceuticals
- Promega
- Novartis
- Oncolys BioPharma
- MDxHealth
- Merck
- Illumina
- Epizyme
- Forum Pharmaceuticals
- EpiGentek
- Chroma Therapeutics
- Celleron Therapeutics
- CellCentric
- Astex Pharmaceuticals
- Acetylon Pharmaceuticals
- 4SC AG
- Eisai
- Pharmacyclics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Epigenetics Drugs and Diagnostic Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epigenetics Drugs and Diagnostic Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES OVERALL MARKET SIZE
2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size: 2021 VS 2028
2.2 Global Epigenetics Drugs and Diagnostic Technologies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Epigenetics Drugs and Diagnostic Technologies Players in Global Market
3.2 Top Global Epigenetics Drugs and Diagnostic Technologies Companies Ranked by Revenue
3.3 Global Epigenetics Drugs and Diagnostic Technologies Revenue by Companies
3.4 Top 3 and Top 5 Epigenetics Drugs and Diagnostic Technologies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epigenetics Drugs and Diagnostic Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Players in Global Market
3.6.1 List of Global Tier 1 Epigenetics Drugs and Diagnostic Technologies Companies
3.6.2 List of Global Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Epigenetics Drugs and Diagnostic Technologies Market Size Markets, 2021 & 2028
4.1.2 HDAC inhibitors
4.1.3 DNMT inhibitors
4.2 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
4.2.1 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
4.2.2 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
4.2.3 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Epigenetics Drugs and Diagnostic Technologies Market Size, 2021 & 2028
5.1.2 Non coding RNA’s
5.1.3 Micro RNA’s
5.1.4 Histone modifications
5.1.5 DNA methylation
5.2 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
5.2.1 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
5.2.2 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
5.2.3 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Epigenetics Drugs and Diagnostic Technologies Market Size, 2021 & 2028
6.2 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
6.2.1 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
6.2.2 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
6.2.3 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.3.2 US Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.3.3 Canada Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.3.4 Mexico Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.4.2 Germany Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.3 France Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.4 U.K. Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.5 Italy Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.6 Russia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.7 Nordic Countries Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.8 Benelux Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.5.2 China Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.3 Japan Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.4 South Korea Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.5 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.6 India Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.6.2 Brazil Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.6.3 Argentina Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.7.2 Turkey Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.3 Israel Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.4 Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.5 UAE Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Varlix Plc
7.1.1 Varlix Plc Corporate Summary
7.1.2 Varlix Plc Business Overview
7.1.3 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.1.4 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.1.5 Varlix Plc Key News
7.2 Topotarget
7.2.1 Topotarget Corporate Summary
7.2.2 Topotarget Business Overview
7.2.3 Topotarget Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.2.4 Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.2.5 Topotarget Key News
7.3 Syndax Pharmaceuticals
7.3.1 Syndax Pharmaceuticals Corporate Summary
7.3.2 Syndax Pharmaceuticals Business Overview
7.3.3 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.3.4 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.3.5 Syndax Pharmaceuticals Key News
7.4 Spectrum Pharmaceuticals
7.4.1 Spectrum Pharmaceuticals Corporate Summary
7.4.2 Spectrum Pharmaceuticals Business Overview
7.4.3 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.4.4 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.4.5 Spectrum Pharmaceuticals Key News
7.5 Promega
7.5.1 Promega Corporate Summary
7.5.2 Promega Business Overview
7.5.3 Promega Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.5.4 Promega Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.5.5 Promega Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.6.4 Novartis Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Oncolys BioPharma
7.7.1 Oncolys BioPharma Corporate Summary
7.7.2 Oncolys BioPharma Business Overview
7.7.3 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.7.4 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.7.5 Oncolys BioPharma Key News
7.8 MDxHealth
7.8.1 MDxHealth Corporate Summary
7.8.2 MDxHealth Business Overview
7.8.3 MDxHealth Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.8.4 MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.8.5 MDxHealth Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.9.4 Merck Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Illumina
7.10.1 Illumina Corporate Summary
7.10.2 Illumina Business Overview
7.10.3 Illumina Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.10.4 Illumina Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.10.5 Illumina Key News
7.11 Epizyme
7.11.1 Epizyme Corporate Summary
7.11.2 Epizyme Business Overview
7.11.3 Epizyme Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.11.4 Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.11.5 Epizyme Key News
7.12 Forum Pharmaceuticals
7.12.1 Forum Pharmaceuticals Corporate Summary
7.12.2 Forum Pharmaceuticals Business Overview
7.12.3 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.12.4 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.12.5 Forum Pharmaceuticals Key News
7.13 EpiGentek
7.13.1 EpiGentek Corporate Summary
7.13.2 EpiGentek Business Overview
7.13.3 EpiGentek Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.13.4 EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.13.5 EpiGentek Key News
7.14 Chroma Therapeutics
7.14.1 Chroma Therapeutics Corporate Summary
7.14.2 Chroma Therapeutics Business Overview
7.14.3 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.14.4 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.14.5 Chroma Therapeutics Key News
7.15 Celleron Therapeutics
7.15.1 Celleron Therapeutics Corporate Summary
7.15.2 Celleron Therapeutics Business Overview
7.15.3 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.15.4 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.15.5 Celleron Therapeutics Key News
7.16 CellCentric
7.16.1 CellCentric Corporate Summary
7.16.2 CellCentric Business Overview
7.16.3 CellCentric Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.16.4 CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.16.5 CellCentric Key News
7.17 Astex Pharmaceuticals
7.17.1 Astex Pharmaceuticals Corporate Summary
7.17.2 Astex Pharmaceuticals Business Overview
7.17.3 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.17.4 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.17.5 Astex Pharmaceuticals Key News
7.18 Acetylon Pharmaceuticals
7.18.1 Acetylon Pharmaceuticals Corporate Summary
7.18.2 Acetylon Pharmaceuticals Business Overview
7.18.3 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.18.4 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.18.5 Acetylon Pharmaceuticals Key News
7.19 4SC AG
7.19.1 4SC AG Corporate Summary
7.19.2 4SC AG Business Overview
7.19.3 4SC AG Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.19.4 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.19.5 4SC AG Key News
7.20 Eisai
7.20.1 Eisai Corporate Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.20.4 Eisai Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.20.5 Eisai Key News
7.21 Pharmacyclics
7.21.1 Pharmacyclics Corporate Summary
7.21.2 Pharmacyclics Business Overview
7.21.3 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.21.4 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.21.5 Pharmacyclics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Epigenetics Drugs and Diagnostic Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epigenetics Drugs and Diagnostic Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES OVERALL MARKET SIZE
2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size: 2021 VS 2028
2.2 Global Epigenetics Drugs and Diagnostic Technologies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Epigenetics Drugs and Diagnostic Technologies Players in Global Market
3.2 Top Global Epigenetics Drugs and Diagnostic Technologies Companies Ranked by Revenue
3.3 Global Epigenetics Drugs and Diagnostic Technologies Revenue by Companies
3.4 Top 3 and Top 5 Epigenetics Drugs and Diagnostic Technologies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Epigenetics Drugs and Diagnostic Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Players in Global Market
3.6.1 List of Global Tier 1 Epigenetics Drugs and Diagnostic Technologies Companies
3.6.2 List of Global Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Epigenetics Drugs and Diagnostic Technologies Market Size Markets, 2021 & 2028
4.1.2 HDAC inhibitors
4.1.3 DNMT inhibitors
4.2 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
4.2.1 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
4.2.2 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
4.2.3 By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Epigenetics Drugs and Diagnostic Technologies Market Size, 2021 & 2028
5.1.2 Non coding RNA’s
5.1.3 Micro RNA’s
5.1.4 Histone modifications
5.1.5 DNA methylation
5.2 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
5.2.1 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
5.2.2 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
5.2.3 By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Epigenetics Drugs and Diagnostic Technologies Market Size, 2021 & 2028
6.2 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue & Forecasts
6.2.1 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2022
6.2.2 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2023-2028
6.2.3 By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.3.2 US Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.3.3 Canada Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.3.4 Mexico Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.4.2 Germany Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.3 France Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.4 U.K. Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.5 Italy Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.6 Russia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.7 Nordic Countries Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.4.8 Benelux Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.5.2 China Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.3 Japan Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.4 South Korea Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.5 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.5.6 India Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.6.2 Brazil Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.6.3 Argentina Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028
6.7.2 Turkey Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.3 Israel Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.4 Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
6.7.5 UAE Epigenetics Drugs and Diagnostic Technologies Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Varlix Plc
7.1.1 Varlix Plc Corporate Summary
7.1.2 Varlix Plc Business Overview
7.1.3 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.1.4 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.1.5 Varlix Plc Key News
7.2 Topotarget
7.2.1 Topotarget Corporate Summary
7.2.2 Topotarget Business Overview
7.2.3 Topotarget Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.2.4 Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.2.5 Topotarget Key News
7.3 Syndax Pharmaceuticals
7.3.1 Syndax Pharmaceuticals Corporate Summary
7.3.2 Syndax Pharmaceuticals Business Overview
7.3.3 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.3.4 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.3.5 Syndax Pharmaceuticals Key News
7.4 Spectrum Pharmaceuticals
7.4.1 Spectrum Pharmaceuticals Corporate Summary
7.4.2 Spectrum Pharmaceuticals Business Overview
7.4.3 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.4.4 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.4.5 Spectrum Pharmaceuticals Key News
7.5 Promega
7.5.1 Promega Corporate Summary
7.5.2 Promega Business Overview
7.5.3 Promega Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.5.4 Promega Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.5.5 Promega Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.6.4 Novartis Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Oncolys BioPharma
7.7.1 Oncolys BioPharma Corporate Summary
7.7.2 Oncolys BioPharma Business Overview
7.7.3 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.7.4 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.7.5 Oncolys BioPharma Key News
7.8 MDxHealth
7.8.1 MDxHealth Corporate Summary
7.8.2 MDxHealth Business Overview
7.8.3 MDxHealth Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.8.4 MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.8.5 MDxHealth Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.9.4 Merck Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Illumina
7.10.1 Illumina Corporate Summary
7.10.2 Illumina Business Overview
7.10.3 Illumina Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.10.4 Illumina Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.10.5 Illumina Key News
7.11 Epizyme
7.11.1 Epizyme Corporate Summary
7.11.2 Epizyme Business Overview
7.11.3 Epizyme Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.11.4 Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.11.5 Epizyme Key News
7.12 Forum Pharmaceuticals
7.12.1 Forum Pharmaceuticals Corporate Summary
7.12.2 Forum Pharmaceuticals Business Overview
7.12.3 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.12.4 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.12.5 Forum Pharmaceuticals Key News
7.13 EpiGentek
7.13.1 EpiGentek Corporate Summary
7.13.2 EpiGentek Business Overview
7.13.3 EpiGentek Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.13.4 EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.13.5 EpiGentek Key News
7.14 Chroma Therapeutics
7.14.1 Chroma Therapeutics Corporate Summary
7.14.2 Chroma Therapeutics Business Overview
7.14.3 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.14.4 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.14.5 Chroma Therapeutics Key News
7.15 Celleron Therapeutics
7.15.1 Celleron Therapeutics Corporate Summary
7.15.2 Celleron Therapeutics Business Overview
7.15.3 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.15.4 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.15.5 Celleron Therapeutics Key News
7.16 CellCentric
7.16.1 CellCentric Corporate Summary
7.16.2 CellCentric Business Overview
7.16.3 CellCentric Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.16.4 CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.16.5 CellCentric Key News
7.17 Astex Pharmaceuticals
7.17.1 Astex Pharmaceuticals Corporate Summary
7.17.2 Astex Pharmaceuticals Business Overview
7.17.3 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.17.4 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.17.5 Astex Pharmaceuticals Key News
7.18 Acetylon Pharmaceuticals
7.18.1 Acetylon Pharmaceuticals Corporate Summary
7.18.2 Acetylon Pharmaceuticals Business Overview
7.18.3 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.18.4 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.18.5 Acetylon Pharmaceuticals Key News
7.19 4SC AG
7.19.1 4SC AG Corporate Summary
7.19.2 4SC AG Business Overview
7.19.3 4SC AG Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.19.4 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.19.5 4SC AG Key News
7.20 Eisai
7.20.1 Eisai Corporate Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.20.4 Eisai Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.20.5 Eisai Key News
7.21 Pharmacyclics
7.21.1 Pharmacyclics Corporate Summary
7.21.2 Pharmacyclics Business Overview
7.21.3 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Major Product Offerings
7.21.4 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue in Global Market (2017-2022)
7.21.5 Pharmacyclics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Epigenetics Drugs and Diagnostic Technologies Market Opportunities & Trends in Global Market
Table 2. Epigenetics Drugs and Diagnostic Technologies Market Drivers in Global Market
Table 3. Epigenetics Drugs and Diagnostic Technologies Market Restraints in Global Market
Table 4. Key Players of Epigenetics Drugs and Diagnostic Technologies in Global Market
Table 5. Top Epigenetics Drugs and Diagnostic Technologies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epigenetics Drugs and Diagnostic Technologies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epigenetics Drugs and Diagnostic Technologies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epigenetics Drugs and Diagnostic Technologies Product Type
Table 9. List of Global Tier 1 Epigenetics Drugs and Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 30. Varlix Plc Corporate Summary
Table 31. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 32. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 33. Topotarget Corporate Summary
Table 34. Topotarget Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 35. Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 36. Syndax Pharmaceuticals Corporate Summary
Table 37. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 38. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 39. Spectrum Pharmaceuticals Corporate Summary
Table 40. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 41. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 42. Promega Corporate Summary
Table 43. Promega Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 44. Promega Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 47. Novartis Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 48. Oncolys BioPharma Corporate Summary
Table 49. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 50. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 51. MDxHealth Corporate Summary
Table 52. MDxHealth Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 53. MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 56. Merck Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 57. Illumina Corporate Summary
Table 58. Illumina Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 59. Illumina Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 60. Epizyme Corporate Summary
Table 61. Epizyme Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 62. Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 63. Forum Pharmaceuticals Corporate Summary
Table 64. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 65. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 66. EpiGentek Corporate Summary
Table 67. EpiGentek Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 68. EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 69. Chroma Therapeutics Corporate Summary
Table 70. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 71. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 72. Celleron Therapeutics Corporate Summary
Table 73. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 74. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 75. CellCentric Corporate Summary
Table 76. CellCentric Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 77. CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 78. Astex Pharmaceuticals Corporate Summary
Table 79. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 80. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 81. Acetylon Pharmaceuticals Corporate Summary
Table 82. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 83. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 84. 4SC AG Corporate Summary
Table 85. 4SC AG Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 86. 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 87. Eisai Corporate Summary
Table 88. Eisai Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 89. Eisai Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 90. Pharmacyclics Corporate Summary
Table 91. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 92. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 1. Epigenetics Drugs and Diagnostic Technologies Market Opportunities & Trends in Global Market
Table 2. Epigenetics Drugs and Diagnostic Technologies Market Drivers in Global Market
Table 3. Epigenetics Drugs and Diagnostic Technologies Market Restraints in Global Market
Table 4. Key Players of Epigenetics Drugs and Diagnostic Technologies in Global Market
Table 5. Top Epigenetics Drugs and Diagnostic Technologies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Epigenetics Drugs and Diagnostic Technologies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Epigenetics Drugs and Diagnostic Technologies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Epigenetics Drugs and Diagnostic Technologies Product Type
Table 9. List of Global Tier 1 Epigenetics Drugs and Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epigenetics Drugs and Diagnostic Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Epigenetics Drugs and Diagnostic Technologies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2023-2028
Table 30. Varlix Plc Corporate Summary
Table 31. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 32. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 33. Topotarget Corporate Summary
Table 34. Topotarget Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 35. Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 36. Syndax Pharmaceuticals Corporate Summary
Table 37. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 38. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 39. Spectrum Pharmaceuticals Corporate Summary
Table 40. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 41. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 42. Promega Corporate Summary
Table 43. Promega Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 44. Promega Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 47. Novartis Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 48. Oncolys BioPharma Corporate Summary
Table 49. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 50. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 51. MDxHealth Corporate Summary
Table 52. MDxHealth Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 53. MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 56. Merck Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 57. Illumina Corporate Summary
Table 58. Illumina Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 59. Illumina Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 60. Epizyme Corporate Summary
Table 61. Epizyme Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 62. Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 63. Forum Pharmaceuticals Corporate Summary
Table 64. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 65. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 66. EpiGentek Corporate Summary
Table 67. EpiGentek Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 68. EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 69. Chroma Therapeutics Corporate Summary
Table 70. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 71. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 72. Celleron Therapeutics Corporate Summary
Table 73. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 74. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 75. CellCentric Corporate Summary
Table 76. CellCentric Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 77. CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 78. Astex Pharmaceuticals Corporate Summary
Table 79. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 80. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 81. Acetylon Pharmaceuticals Corporate Summary
Table 82. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 83. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 84. 4SC AG Corporate Summary
Table 85. 4SC AG Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 86. 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 87. Eisai Corporate Summary
Table 88. Eisai Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 89. Eisai Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
Table 90. Pharmacyclics Corporate Summary
Table 91. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Product Offerings
Table 92. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Epigenetics Drugs and Diagnostic Technologies Segment by Type in 2021
Figure 2. Epigenetics Drugs and Diagnostic Technologies Segment by Application in 2021
Figure 3. Global Epigenetics Drugs and Diagnostic Technologies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue in 2021
Figure 8. By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 12. US Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 16. Germany Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 17. France Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 24. China Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 28. India Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 30. Brazil Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 33. Turkey Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 37. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Promega Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Illumina Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Eisai Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Epigenetics Drugs and Diagnostic Technologies Segment by Type in 2021
Figure 2. Epigenetics Drugs and Diagnostic Technologies Segment by Application in 2021
Figure 3. Global Epigenetics Drugs and Diagnostic Technologies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Epigenetics Drugs and Diagnostic Technologies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue in 2021
Figure 8. By Type - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 12. US Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 16. Germany Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 17. France Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 24. China Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 28. India Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 30. Brazil Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Revenue Market Share, 2017-2028
Figure 33. Turkey Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Epigenetics Drugs and Diagnostic Technologies Revenue, (US$, Mn), 2017-2028
Figure 37. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Topotarget Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Promega Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MDxHealth Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Illumina Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Epizyme Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. EpiGentek Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. CellCentric Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. 4SC AG Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Eisai Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
